• Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      South Africa's Aspen, India's Lupin in TB drugs

      Posted AtReuters

      Africa's biggest generics drugs maker Aspen has concluded a joint venture with India's Lupin to collaborate on tuberculosis (TB) related products in South Africa, it said on Monday.

      HIV/AIDS, which affects more people in South Africa than any other country, has raised TB infection rates, placing immense pressure on stretched healthcare resources.

      Aspen said in a statement that its agreement with Lupin involved cooperation in technology, manufacture and marketing.

      Aspen said the market for TB medication in South Africa was worth around $15 million per annum and it expected to pay up to $2 million to Lupin depending on certain conditions, although it did not give a time scale for such payments.

      The parties will also share profits from the joint venture.

      Mumbai-based Lupin makes and markets generic intermediates, active pharmaceutical ingredients and finished drug dosages. Eleven of Lupin's plants have been approved by U.S. regulators and two of its facilities have been approved by UK authorities.

      Last week Aspen agreed terms for two joint ventures with another Indian group, Matrix Laboratories, to cater for South Africa's large demand for AIDS medication.

      September 26, 2005


      Share this Article!

    Back to top^